The Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (NASDAQ:CGABL) Sees Significant Drop in Short Interest

The Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (NASDAQ:CGABL) was the target of a significant decrease in short interest during the month of February. As of February 15th, there was short interest totalling 11,500 shares, a decrease of 51.1% from the January 31st total of 23,500 shares. Based on an average daily trading volume, of 31,500 shares, the short-interest ratio is presently 0.4 days.

Carlyle Group Inc. 4.625% Subordinated Notes due 2061 Stock Up 0.3 %

Carlyle Group Inc. 4.625% Subordinated Notes due 2061 stock opened at $18.03 on Friday. The stock has a 50 day moving average of $18.16 and a two-hundred day moving average of $19.06. Carlyle Group Inc. 4.625% Subordinated Notes due 2061 has a twelve month low of $17.48 and a twelve month high of $20.85.

Carlyle Group Inc. 4.625% Subordinated Notes due 2061 Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Saturday, February 15th. Investors of record on Saturday, February 1st were issued a dividend of $0.2891 per share. The ex-dividend date was Friday, January 31st. This is an increase from Carlyle Group Inc. 4.625% Subordinated Notes due 2061’s previous quarterly dividend of $0.29. This represents a $1.16 annualized dividend and a dividend yield of 6.41%.

Carlyle Group Inc. 4.625% Subordinated Notes due 2061 Company Profile

biohaven is engaged in the identification and development of clinical stage compounds targeting the glutamatergic system. biohaven obtained licenses from yale university school of medicine and massachusetts general hospital regarding intellectual property relating to the use of certain glutamate modulating agents in the treatment of neuropsychiatric disorders.